Clinical Study Results
What happened during the study?
Before treatment, the participants visited their study site 1 time. During this visit,
the study doctors:
• did tests and physical exams to make sure the participants could join the study
• asked the participants how they were feeling
• checked the participants’ heart health using an electrocardiogram, also called
an ECG
During treatment, the participants visited their study site 1 time and stayed there
for 11 days. The participants took their study treatment on 8 of these 11 days. They
took either AZD9977 or the placebo as a liquid by mouth. The doses of AZD9977
were measured in milligrams, also called mg.
The table below shows the treatments the participants took.
6 participants took 50 mg All 27 participants took their
of AZD9977 study treatment:
6 participants took 150 mg 1 time on the first and
of AZD9977 eighth day
2 times a day on the second
6 participants took 300 mg
through seventh days
of AZD9977
9 participants took the placebo
Throughout treatment, the study doctors checked the overall health and heart health
of the participants and asked them how they were feeling.
After treatment, the participants visited their study site 1 time about 1 week after
they took their last treatment. At this visit, the study doctors checked the overall
health and heart health of the participants and asked them how they were feeling.
What were the results of the study?
This is a summary of the main results from this study overall. The results each
participant had might be different and are not in this summary.
3